MicroRNAs and cell cycle of malignant glioma

Qing Ouyang1, Lunshan Xu1, Hongjuan Cui2

  • 1a Department of Neurosurgery, Daping Hospital & Research Institute of Surgery , Third Military Medical University , Chongqing , China.

Insights

MicroRNAs (miRNAs) regulate the glioma cell cycle. Dysregulated miRNAs and transcription factors contribute to glioma proliferation, making miRNAs potential biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of the malignant glioma cell cycle.
  • Deregulation of miRNAs contributes to glioma proliferation by affecting cell-cycle regulators.
  • Both tumor-suppressive and oncogenic miRNAs play roles in cell-cycle control.

Purpose of the Study:

  • To explore the role of microRNAs (miRNAs) in malignant glioma cell-cycle control.
  • To investigate the interplay between transcription factors and miRNAs in glioma.
  • To identify miRNAs as potential biomarkers and therapeutic targets for glioma.

Main Methods:

  • Review of existing literature on miRNA and transcription factor involvement in glioma.
  • Analysis of regulatory networks governing the glioma cell cycle.
  • Identification of specific miRNAs targeting cell-cycle regulators.

Main Results:

  • MiRNAs directly target positive and negative cell-cycle regulators, influencing glioma proliferation.
  • Transcription factors are involved in regulating miRNA expression, and their deregulation can impact miRNA levels.
  • Abnormal miRNA expression is implicated in glioma cell-cycle dysregulation.

Conclusions:

  • MiRNAs are critical in regulating the glioma cell cycle.
  • The interplay between transcription factors and miRNAs is crucial in glioma pathogenesis.
  • MiRNAs represent promising biomarkers and therapeutic targets for malignant glioma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K